I'm a physician at the Dana-Farber Cancer Institute. Specifically, I am the Clinical Director of the Center for Neuro-Oncology.
Our Center focuses on developing better treatments, providing the very best care available anywhere and supporting our patients and their families/caregivers, who battle cancers of the brain and spine.
Although not as common as other cancers, primary cancers of the brain/spine are among the most deadly, with outcomes that leave much room for improvement. In addition, our Center also helps patients with cancers that arise elsewhere in the body and spread to the brain/spine (metastatic brain tumors). These are quite common and also very challenging to treat.
I am proud and privileged to work with an outstanding multidisciplinary team of world class specialists at the Dana-Farber/BWH who together, are making a difference.
Nonetheless, we critically need to do more and we need to do it faster. We are working tirelessly in the lab and in the clinic to better understand these cancers and identify successful strategies to defeat them.
Currently a major effort in the lab and clinic is the development of immunotherapies - strategies to use the body's natural defenses to attack and destroy cancer, and then to prevent its recurrence. Immunotherapy treatments have shown remarkable success recently for other cancers, but their role for brain cancers remains unknown. Five years ago, we had no immunotherapy clinical trials at the Dana-Farber. Today we have a half a dozen and more in development. We also have a strong laboratory effort to better understand these approaches in order to increase our likelihood of success in the clinic. Nonetheless, we can not move these promising therapies forward without your help. Funding from federal grants and pharmaceutical companies remains low especially in the current political climate in the US. Your support is critically needed.
Cancer affects all of us. The PMC is a great event to raise awareness and support for cancer research. My wife Beth and I have been major PMC fans, and 2024 will be our 10th year participating in the PMC. We are honored to join the other riders to support this great event and humbled by the support shown to us. Through the PMC we will endeavor to continue to move closer to a cure for patients and familieis afflicted with primary and metastatic brain cancers.
Thank you.
Dave and Beth Reardon
I'm a physician at the Dana-Farber Cancer Institute. Specifically, I am the Clinical Director of the Center for Neuro-Oncology.
Our Center focuses on developing better treatments, providing the very best care available anywhere and supporting our patients and their families/caregivers, who battle cancers of the brain and spine.
Although not as common as other cancers, primary cancers of the brain/spine are among the most deadly, with outcomes that leave much room for improvement. In addition, our Center also helps patients with cancers that arise elsewhere in the body and spread to the brain/spine (metastatic brain tumors). These are quite common and also very challenging to treat.
I am proud and privileged to work with an outstanding multidisciplinary team of world class specialists at the Dana-Farber/BWH who together, are making a difference.
Nonetheless, we critically need to do more and we need to do it faster. We are working tirelessly in the lab and in the clinic to better understand these cancers and identify successful strategies to defeat them.
Currently a major effort in the lab and clinic is the development of immunotherapies - strategies to use the body's natural defenses to attack and destroy cancer, and then to prevent its recurrence. Immunotherapy treatments have shown remarkable success recently for other cancers, but their role for brain cancers remains unknown. Five years ago, we had no immunotherapy clinical trials at the Dana-Farber. Today we have a half a dozen and more in development. We also have a strong laboratory effort to better understand these approaches in order to increase our likelihood of success in the clinic. Nonetheless, we can not move these promising therapies forward without your help. Funding from federal grants and pharmaceutical companies remains low especially in the current political climate in the US. Your support is critically needed.
Cancer affects all of us. The PMC is a great event to raise awareness and support for cancer research. My wife Beth and I have been major PMC fans, and 2024 will be our 10th year participating in the PMC. We are honored to join the other riders to support this great event and humbled by the support shown to us. Through the PMC we will endeavor to continue to move closer to a cure for patients and familieis afflicted with primary and metastatic brain cancers.
Thank you.
Dave and Beth Reardon
I have chosen to keep all of my donors' information confidential; therefore it is not displayed on my PMC public donor list.
